The factsheet has been successfully sent.
Please check your inbox.
Favor proporcione sus datos para recibir la ficha informativa en su email
Enviar
Cancelar

0
Usted tienen ítems en la lista de mayor información
Solicitar la información ahora

12 April 2024 [Comunicado de prensa]

STI Awareness Week

The CDC's STI Awareness Week underscores the public health priority of Sexually Transmitted Infections (STIs). It provides an opportunity to raise awareness about STIs and how they impact our lives. Tackling this global issue involves mitigating the associated stigma and discrimination, and ensuring people have the tools and knowledge for prevention, testing and treatment.1

According to CDC estimates, around 1 in 5 people in the US have an STI, with almost half of new infections occuring among youth aged 15-24 years of age. Despite this prevalence, less than 12% of young people get tested for STIs.2 This all adds up to nearly $16 billion in direct medical costs to the American health care system each year.1

In addition to prevention measures, such as lifestyle changes, effective testing strategies are critical to limit the spread of these infections. DiagCor Life Science offers several molecular diagnostic tests for STIs, including GenoFlowTM STD Array Test KitGenoQuestTM CA/GV qPCR Assay and GenoQuestTM HSV-1/2 qPCR Assay. Get in touch to learn more!

Acerca de DiagCor

Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.



Contacto de prensa

DiagCor Life Science

[email protected]